$NVLX According to the American cancer Society, in the US

New Post Public Reply Private Reply Replies (0) Message Board
Tandrel
$NVLX According to the American cancer Society, in the US alone, approximately 45,000 new cases of pancreatic cancer are expected to be diagnosed this year and about 38,000 people are predicted to die from the disease; it is the leading cause of cancer deaths in the US and worldwide. Often pancreatic cancer is not diagnosed until it has reached an advanced stage. By this time, the cancer cannot be removed surgically, is often resistant to radiation therapy or chemotherapy, and has spread (metastasized) to other organs in the body. Because of this, the average survival of patients with advanced, inoperable pancreatic cancer is given in terms of weeks or months, not years.Nuvilex’s pancreatic cancer treatment consists of the use of a proprietary cellulose-based live-cell encapsulation technology together with the long-known and widely used anticancer drug ifosfamide.In a Phase I/II open-label, prospective, single-arm clinical trial, the live-cell encapsulation/ifosfamide combination was used to treat patients with advanced, inoperable pancreatic cancer. Fifty-one patients were originally “screened” for the trial; of these, 17 were enrolled in the study. Other patients were excluded from enrollment for therapy because of previous chemotherapy, previous pancreatic surgery, poor overall health, unwillingness to participate, or death prior to the start of the trial. Of the 17 patients initially enrolled in the study, 14 were ultimately treated. Results obtained in the clinical trial were compared with historical data for gemcitabine and included: median survival time of 44 weeks (after diagnosis) with the cell encapsulation/ifosfamide treatment as compared to 28 weeks with gemcitabine; doubling of the one-year survival rate – 36% with our treatment vs. 18% with gemcitabine; tumor volume was reduced 25-50% in 4 of the 14 treated patients and remained stable in the remaining patients; no serious drug-related side effects with the encapsulated cell/ifosfamide treatment whereas serious and very serious side effects were reported with gemcitabine; the lack of serious side effects using our treatment is probably related to the use of “lower than normal” doses of ifosfamide; limited side effects and reduced cancer pain intensity led to a generally increased ‘quality of life” for the majority of patients. In a “worst case” scenario, some clinical benefit was seen in 50% of patients and in a “best case” scenario, this number increased to 71%; none of the patients who experienced a clinical benefit required and increase in their pain medication.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ZKONG, Hagebau Push ESLs in European Retail Revamp

Updated Category News Views 156

ESLs: The Next Step in Retail Revamp Here’s the scoop: ZKONG and hagebau are making waves in the retail scene over in Germany. They’re bringing in Electronic Shelf Labels (ESLs) to kick traditional price tags to the curb. What started as a shake-up in supermarkets now rolls into the world of home improvement retail—headline by hagebaumarkt in Selb after nearly half...

Continue Reading
ChinaMarket: Linyi's Gateway for Global Buying Delegations

Updated Category News Views 64

Unlocking Trade Potential in Linyi, China Linyi, in Shandong province, has flipped the switch on the sourcing circuit with one powerful invite to global buying delegations. As we sit perched on the fence of an economically tangled world, China's open arms to Southeast and Central Asian buyers mark a significant shift towards more fluid trade connections. The Fourth Linyi...

Continue Reading
Texas Home Boasts PGA-Caliber Green with Synthetic Turf

Updated Category News Views 13

Swinging for Luxury in Your Backyard Who'd have thought that a chunk of Austin, Texas, could boast a putting green that’s giving any PGA course a run for its money? We’re talking about a family here who decided they’d had enough of scalding summers and winter chills and wanted a taste of that country club glam at home without the upkeep headaches. The Rise of...

Continue Reading
TCL CSOT Displays Shine in TIME’s 2026 Inventions

Updated Category News Views 10

Breaking Boundaries with Display Technology Ah, the tech game—if you're not moving forward, you're slipping into obscurity. TCL must be grinning ear to ear as its displays just snagged a coveted spot on TIME's Best Inventions of 2026 list. We're talking about the TCL X11L SQD-Mini LED TV, the XTEINK X4 Pro Pocket eReader, and the Framework Laptop 13 Pro. Yep, all...

Continue Reading
Shareholder Stakes at Risk in Major Mergers

Updated Category News Views 52

Deals in the Spotlight: What's at Stake? Ever wonder if you're getting the short end of the stick while company insiders walk away with the spoils? That's the song and dance investors face with the likes of ADT Inc., Instacart, and MidCap Financial Investment Corporation lately. If you're wearing the shareholder hat, you might want to tune into the noise around these...

Continue Reading
BingX's AI Enjoys Roaring Adoption in Trading

Updated Category News Views 70

Traders and their AI tools—sounds like a match made in market heaven, right? That's the buzz coming out of BingX, the multi-asset trading platform that's been shaking things up in the fintech realm. These days, it seems like everyone's hitching a ride on the AI train. Explosive Growth in AI Utilization Now, let's talk numbers, and boy, are these numbers juicy. Daily...

Continue Reading
Aries Unveils Prediction Markets Amid Midterm Fervor

Updated Category News Views 103

Aries Enters Prediction Markets Ah, Aries is diving into the world of prediction markets, riding the wave of excitement around the 2026 U.S. midterm elections. They're tossing their hat in the ring with Aries Mobile, letting eligible customers toy with event contracts on not just political outcomes, but economic data and financial market trends too. With ForecastEx LLC,...

Continue Reading
Twilio's SEC Investigation: Legal Impacts on Investors

Updated Category News Views 38

Twilio's Legal Troubles: Investors Take Notice Twilio's facing a firestorm, folks. After guiding its organic revenue growth down a few notches, the company saw its shares plummet 17%. Now, they're under the microscope for possibly not playing it straight with their growth numbers, and that’s never a good look with Uncle Sam watching. Folks at Levi & Korsinsky are on the...

Continue Reading
KSAT and MSU Boost Lunar Network for Space Growth

Updated Category News Views 66

Breaking Ground in Space: KSAT and MSU Join Forces Here's a cosmic twist in the world of satellite communications: KSAT and Morehead State University (MSU) are teaming up to expand the lunar frontier. This ain't small potatoes; it's a strategic handshake aimed at beefing up KSAT's lunar network. They're set to amplify support for the growing hunger in deep space...

Continue Reading
Beta Bionics Faces Class Action Deadline Amid Controversy

Updated Category News Views 16

Beta Bionics' Investors in a Bind: Lead Plaintiff Opportunity Looms Alright, folks, it’s time to size up the situation at Beta Bionics, Inc. (NASDAQ: BBNX). If you're holding onto their stock and nursing some serious losses, you're not alone. The clock's ticking on the November 3, 2026 deadline to step up and lead the charge in a class action lawsuit. What's the Fuss...

Continue Reading

Top 5 Most Recently Viewed Articles

Leadership Transition at McEwen Inc. with Ian Ball's Appointment

Updated Category News Views 220

New Vice-Chairman at McEwen Inc. McEwen Inc. (NYSE: MUX, TSX: MUX) has made an important announcement regarding its leadership structure. The company has appointed Ian Ball as the Vice-Chairman, a newly created executive position aimed at bolstering the company's strategic growth initiatives. This appointment underscores McEwen's dedication to enhancing its leadership...

Continue Reading
Robert Brooks Takes Leadership Role at Southern Glazer's

Updated Category News Views 306

Robert Brooks Takes Leadership Role at Southern Glazer's In an exciting development for Southern Glazer's Wine & Spirits, Robert (Bob) Brooks has been appointed as the Executive Vice President and General Manager for New Mexico. This strategic move reaffirms the company's commitment to strengthening its presence in the beverage distribution sector. Brooks's Journey Within...

Continue Reading
Exploring Earnings Projections for Commercial Vehicle Group

Updated Category News Views 156

Understanding the Earnings Outlook for Commercial Vehicle Group Commercial Vehicle Group (NASDAQ: CVGI) is preparing to unveil its quarterly earnings, and investors are keen to learn what lies ahead for this company. As anticipation builds for the earnings report, it's essential to delve into what this announcement could signify for shareholders. Expected Earnings Report...

Continue Reading
Ryan Barone of RentRedi Selected as Future Leader in Real Estate

Updated Category News Views 454

Ryan Barone Honored as a Transformative Leader RentRedi, a leader in property management technology, is excited to announce that its Co-founder and CEO Ryan Barone has been recognized as one of the innovative leaders in the real estate sector by being named a Future Leader. This honor, awarded in the Technology & Data category, signifies Ryan's exceptional vision and...

Continue Reading
Clinical Decision Support Systems Market Growth Projections

Updated Category News Views 192

Transformative Growth in Clinical Decision Support Systems As the healthcare sector continues to evolve, the acceleration in adopting healthcare IT is markedly reshaping global delivery systems. Improved patient safety and stringent government initiatives are creating an environment ripe for innovation. In this exciting phase, the clinical decision support systems (CDSS)...

Continue Reading